Congenital Anomalies Treatment Market Size

Congenital Anomalies Treatment Market size was valued at USD 158.5 million in 2023 and is likely to reach USD 284.41 million by 2036, registering around 4.6% CAGR during the forecast period i.e., between 2024-2036. In the year 2024, the industry size of congenital anomalies treatment is estimated at USD 164.33 million.

 The growth of the market can be attributed to the increasing prevalence of congenital anomalies amongst new born babies. Congenital anomalies or abnormalities can be caused due to various factors, including genetic makeup, environmental, socioeconomic or demographic factors, poor maternal nutritional status, and infections caught during pregnancies. According to the data by the World Health Organization (WHO), 295,000 newborns die within 28 days of birth every year, due to congenital anomalies, globally. Moreover, prevention of these anomalies is near to impossible, as the causes are vague and uncontrollable. A WHO report stated that over 50% of all congenital anomalies cannot be linked to a specific cause. As a result, treatment is the only solution for congenital abnormalities, leading to a high demand for treatment, which is estimated to boost the market growth. Furthermore, growing healthcare awareness amongst the parents, along with availability of advanced treatment options are anticipated to further propel the congenital anomalies treatment market growth. In addition to this, the increasing government investment in the field of medical research, is projected to further propel the market growth.